AIM IMMUNOTECH INC. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-07: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-07: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-07: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-07: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-07 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-07 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-07 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-07 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-03-27 10-K | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-03-27 10-K | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | we have not adopted a formal policy pertaining to the timing of stock option grants to our named executive officers, it is our practice no t to time the grant of equity awards, including stock options, in relation to the release of material non-public information (“MNPI”). Similarly, the Company doe… | |
| 2026-03-27 10-K | Award Timing MNPI Considered | 2025-01-01..2025-12-31 | No | |
| 2026-03-27 10-K | MNPI Disclosure Timed For Compensation Val | 2025-01-01..2025-12-31 | No | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYear; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYears; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYear; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValue; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYears; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYear; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValue; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYears; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYear; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValue; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYears; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValue; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYears; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValue; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYears; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToVestInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValue; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | |
| 2025-10-29 DEF 14A | Award Timing MNPI Disclosure | 2024-01-01..2024-12-31 | From time to time, we grant stock options to our employees, including our named executive officers. Historically, we have granted new-hire equity awards, which often include stock options, on or soon after a new hire’s employment start date and annual awards, which often include stock options, gener… | |
| 2025-10-29 DEF 14A | Award Timing Predetermined | 2024-01-01..2024-12-31 | No | |
| 2025-10-29 DEF 14A | Award Timing MNPI Considered | 2024-01-01..2024-12-31 | No | |
| 2025-10-29 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2024-01-01..2024-12-31 | No | |
| 2025-10-29 DEF 14A | Pay versus Performance Table | 2024-01-01..2024-12-31 | Year Summary Compensation Table Total for PEO (1) Compensation Actually Paid to PEO (1) (2) (3) Average Summary Compensation Table Total for Non-PEO NEOs (1) Average Compensation Actually Paid to Non-PEO NEOs (1) (2) Value of Initial Fixed $100 Investment Based On Total Shareholder Return (4) Net In… | |
| 2025-10-29 DEF 14A | Named Executive Officers Footnote | 2024-01-01..2024-12-31 | (1) The principal executive officer (“ PEO ”) and the non-PEO NEOs for each year are as follows: 2024 and 2023: Thomas K. Equels , PEO; Robert Dickey and Peter Rodino, NEOs. 2022: Thomas K. Equels , PEO. Ellen Lintal was our PFO until April 3, 2022, and her compensation for 2022 (including her consu… | |
| 2025-10-29 DEF 14A | Adjustment To PEO Compensation Footnote | 2024-01-01..2024-12-31 | Year Summary Compensation Table Total for PEO Less: Summary Compensation Table Reported Value of Equity Awards(a) Plus: Equity Award Adjustments(b) Equals: Compensation Actually Paid to PEO 2024 $ 1,089,725 $ (200,000 ) $ 177,384 $ 1,067,109 2023 $ 1,431,301 $ (128,112 ) $ 155,350 $ 1,458,539 2022 $… | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsValueInCompensationTable; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$200.00K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsAdjustments; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $177.38K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsValueInCompensationTable; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | -$128.11K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsAdjustments; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $155.35K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsValueInCompensationTable; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$111.56K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsAdjustments; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$5.09K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYear; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $200.00K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDate; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$22.62K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYear; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $108.56K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYear; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $9.87K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDate; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $36.93K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYear; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $79.43K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYear; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $7.22K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDate; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$91.75K |
| 2025-10-29 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2024-01-01..2024-12-31 | The dollar amounts reported in the “ Average Compensation Actually Paid to Non-PEO NEOs ” column represent the average amount of “ compensation actually paid ” to the NEOs as a group (excluding the PEO), as computed in accordance with SEC rules. The dollar amounts do not reflect the actual amount of… | |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: LessSummaryCompensationTableAverageReportedValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$25.00K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageEquityAwardAdjustments; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $21.23K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: LessSummaryCompensationTableAverageReportedValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$21.35K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageEquityAwardAdjustments; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $26.65K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: LessSummaryCompensationTableAverageReportedValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$33.80K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageEquityAwardAdjustments; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$9.45K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $25.00K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDate; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$3.77K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $18.09K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $1.65K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDate; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $6.92K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $10.43K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: VestingDateFairValueOfEquityAwardsGrantedInTheCoveredYearThatVestedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $8.83K |
| 2025-10-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheCoveredYearFromPriorYearEndtoVestingDate; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$28.70K |
| 2025-10-29 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2024-01-01..2024-12-31 | Compensation Actually Paid versus Company Total Shareholder Return As outlined in the table, increases in the compensation actually paid values for our PEO and non-PEO NEOs from 2022 to 2024 are directionally aligned with the changes in our total shareholder return over this same period. The decreas… | |
| 2025-10-29 DEF 14A | Compensation Actually Paid Vs Net Income | 2024-01-01..2024-12-31 | Compensation Actually Paid versus Company Net Income As outlined in the table, decreases in the compensation values for our PEO and non-PEO NEOs occured from 2022 through 2024, while the net losses decreased for same period. The decrease in compensation actually paid from 2022 to 2024 is primarily t… | |
| 2025-03-27 10-K | Insider Trading Policies Proc Adopted | 2024-01-01..2024-12-31 | Yes | |
| 2025-03-27 10-K | Award Timing MNPI Disclosure | 2024-01-01..2024-12-31 | we have not adopted a formal policy pertaining to the timing of stock option grants to our named executive officers, it is our practice no t to time the grant of equity awards, including stock options, in relation to the release of material non-public information (“MNPI”). Similarly, the Company doe… | |
| 2025-03-27 10-K | Award Timing MNPI Considered | 2024-01-01..2024-12-31 | No | |
| 2025-03-27 10-K | MNPI Disclosure Timed For Compensation Val | 2024-01-01..2024-12-31 | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |